Found: 20
Select item for more details and to access through your institution.
BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer.
- Published in:
- Scientific Reports, 2015, p. 17499, doi. 10.1038/srep17499
- By:
- Publication type:
- Article
Convergent Akt activation drives acquired EGFR inhibitor resistance in lung cancer.
- Published in:
- Nature Communications, 2017, v. 8, n. 1, p. 1, doi. 10.1038/s41467-017-00450-6
- By:
- Publication type:
- Article
Combined FGFR and Akt pathway inhibition abrogates growth of FGFR1 overexpressing EGFR-TKI-resistant NSCLC cells.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00208-w
- By:
- Publication type:
- Article
Selective isolation of extracellular vesicles from minimally processed human plasma as a translational strategy for liquid biopsies.
- Published in:
- Biomarker Research, 2022, v. 10, n. 1, p. 1, doi. 10.1186/s40364-022-00404-1
- By:
- Publication type:
- Article
Selective isolation of extracellular vesicles from minimally processed human plasma as a translational strategy for liquid biopsies.
- Published in:
- Biomarker Research, 2022, v. 10, n. 1, p. 1, doi. 10.1186/s40364-022-00404-1
- By:
- Publication type:
- Article
AURKB as a target in non-small cell lung cancer with acquired resistance to anti-EGFR therapy.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-09734-5
- By:
- Publication type:
- Article
Detecting ALK, ROS1, and RET fusions and the METΔex14 splicing variant in liquid biopsies of non‐small‐cell lung cancer patients using RNA‐based techniques.
- Published in:
- Molecular Oncology, 2023, v. 17, n. 9, p. 1884, doi. 10.1002/1878-0261.13468
- By:
- Publication type:
- Article
Digital multiplexed analysis of circular RNAs in FFPE and fresh non-small cell lung cancer specimens.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 12, p. 2367, doi. 10.1002/1878-0261.13182
- By:
- Publication type:
- Article
Multiplex RNA‐based detection of clinically relevant MET alterations in advanced non‐small cell lung cancer.
- Published in:
- Molecular Oncology, 2021, v. 15, n. 2, p. 350, doi. 10.1002/1878-0261.12861
- By:
- Publication type:
- Article
Comprehensive analysis of the clinicopathological features, targetable profile, and prognosis of mucinous adenocarcinoma of the lung.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2021, v. 147, n. 12, p. 3709, doi. 10.1007/s00432-021-03609-3
- By:
- Publication type:
- Article
Cancer Stem Cell Biomarkers in EGFR-Mutation-Positive Non-Small-Cell Lung Cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
RNA-Based Multiplexing Assay for Routine Testing of Fusion and Splicing Variants in Cytological Samples of NSCLC Patients.
- Published in:
- Diagnostics (2075-4418), 2021, v. 11, n. 1, p. 15, doi. 10.3390/diagnostics11010015
- By:
- Publication type:
- Article
RNA Analysis as a Tool to Determine Clinically Relevant Gene Fusions and Splice Variants.
- Published in:
- Archives of Pathology & Laboratory Medicine, 2018, v. 142, n. 4, p. 474, doi. 10.5858/arpa.2017-0134-RA
- By:
- Publication type:
- Article
BID expression determines the apoptotic fate of cancer cells after abrogation of the spindle assembly checkpoint by AURKB or TTK inhibitors.
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01815-w
- By:
- Publication type:
- Article
Identification of ALK, ROS1, and RET Fusions by a Multiplexed mRNA-Based Assay in Formalin-Fixed, Paraffin-Embedded Samples from Advanced Non-Small-Cell Lung Cancer Patients.
- Published in:
- Clinical Chemistry, 2017, v. 63, n. 3, p. 751, doi. 10.1373/clinchem.2016.265314
- By:
- Publication type:
- Article
Author Correction: BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer.
- Published in:
- 2023
- By:
- Publication type:
- Product Review
Response to crizotinib in a non-small-cell lung cancer patient harboring an EML4-ALK fusion with an atypical LTBP1 insertion.
- Published in:
- OncoTargets & Therapy, 2018, v. 11, p. 1117, doi. 10.2147/OTT.S148363
- By:
- Publication type:
- Article
Fluorescence In Situ Hybridization (FISH) for the Characterization and Monitoring of Primary Cultures from Human Tumors.
- Published in:
- Journal of Molecular Pathology, 2023, v. 4, n. 1, p. 57, doi. 10.3390/jmp4010007
- By:
- Publication type:
- Article
Multiplex Analysis of CircRNAs from Plasma Extracellular Vesicle-Enriched Samples for the Detection of Early-Stage Non-Small Cell Lung Cancer.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 10, p. N.PAG, doi. 10.3390/pharmaceutics14102034
- By:
- Publication type:
- Article
Immunotherapy Bridge 2017 and Melanoma Bridge 2017: meeting abstracts.
- Published in:
- 2018
- By:
- Publication type:
- Abstract